DLL3 and neuroendocrine carcinoma: In separate analyses of both pulmonary and GEP-NEN, DLL3 expression was again strongly associated with NEC (p < 0.001, respectively) with higher fractions of DLL3 expression in pulmonary NEC (130/166, 78.3%) compared to GEP-NEC (58/133, 43.6%).